Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07123649) titled 'Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO Study' on Aug. 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Health Services Research. Masking: None (Open Label).
Primary Sponsor: Dana-Farber Cancer Institute
Condition:
Breast Cancer
Intervention:
Behavioral: Shared Decision-Making Toolkit
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: February 2026
Target Sample Size: 364
Countries of Recruitment:
United States
To know more, visit https://c...